15,977 Shares in Orthofix Medical Inc. (NASDAQ:OFIX) Purchased by Inceptionr LLC

Inceptionr LLC bought a new position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 15,977 shares of the medical device company’s stock, valued at approximately $279,000.

Other institutional investors have also added to or reduced their stakes in the company. GSA Capital Partners LLP bought a new position in shares of Orthofix Medical during the third quarter valued at approximately $312,000. Victory Capital Management Inc. boosted its position in Orthofix Medical by 3.3% during the 3rd quarter. Victory Capital Management Inc. now owns 64,807 shares of the medical device company’s stock valued at $1,012,000 after acquiring an additional 2,074 shares in the last quarter. Quest Partners LLC increased its holdings in shares of Orthofix Medical by 187.1% in the 3rd quarter. Quest Partners LLC now owns 13,908 shares of the medical device company’s stock valued at $217,000 after acquiring an additional 9,063 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Orthofix Medical by 17.0% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 34,632 shares of the medical device company’s stock worth $541,000 after acquiring an additional 5,039 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Orthofix Medical by 14.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 324,807 shares of the medical device company’s stock worth $5,073,000 after acquiring an additional 39,901 shares in the last quarter. Hedge funds and other institutional investors own 89.76% of the company’s stock.

Insider Activity at Orthofix Medical

In other Orthofix Medical news, CEO Massimo Calafiore sold 9,203 shares of the company’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $17.14, for a total transaction of $157,739.42. Following the transaction, the chief executive officer now owns 124,151 shares in the company, valued at approximately $2,127,948.14. This represents a 6.90 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Julie Andrews sold 4,655 shares of Orthofix Medical stock in a transaction on Thursday, January 16th. The stock was sold at an average price of $17.89, for a total transaction of $83,277.95. Following the sale, the chief financial officer now owns 28,312 shares of the company’s stock, valued at $506,501.68. The trade was a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 25,442 shares of company stock valued at $436,883 in the last three months. 2.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on OFIX. Roth Mkm reiterated a “buy” rating and issued a $22.00 target price on shares of Orthofix Medical in a research note on Wednesday, February 26th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $24.00 price objective on shares of Orthofix Medical in a research report on Wednesday, February 26th. Finally, StockNews.com upgraded shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $23.33.

Orthofix Medical Trading Up 2.1 %

Orthofix Medical stock opened at $17.16 on Monday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39. The stock has a market cap of $655.75 million, a PE ratio of -5.48 and a beta of 1.06. The stock has a 50-day moving average of $17.89 and a two-hundred day moving average of $17.41. Orthofix Medical Inc. has a one year low of $12.08 and a one year high of $20.73.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.